🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Viatris Inc.

VTRS Healthcare
$16.24 +$0.07 (0.46%)
Market Cap: $18.66 B
Gurus Holding
13
Popularity Rank
#199
% of Shares Held
8.97%
Net Activity (Q2 2026)
-$30.67 M

Guru Ownership Trend

Guru Analysis for Viatris Inc. (VTRS)

Viatris Inc. (VTRS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 13 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.67 B.

Top institutional holders include Chris Davis and Larry Robbins.

Notably, Chris Davis has expressed high conviction in this stock, allocating 5.13% of their equity portfolio to it.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $30.67 M net outflow during the quarter.

Recent activity highlights Ray Dalio who increased their stake by 134.0%. Conversely, Steven Cohen reduced exposure by 68.3%.

Key Holders

Top 5 by Value

$1.19 B
$156.85 M
$74.56 M
$69.47 M
$44.04 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$68.26 M
Total Buy Value
New Buys 1
Additions 5
-$98.93 M
Total Sell Value
Reductions 7
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
8
Net Buyers
6

FAQs for Viatris Inc. (VTRS)

Major holders include Chris Davis ($1.19 B), Larry Robbins ($156.85 M), Cliff Asness ($74.56 M). According to the latest reported data, 13 tracked investment managers collectively hold approximately 103.06 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $30.67 M, with 6 managers increasing positions and 8 managers reducing holdings.

During the most recent reporting period, 7 managers trimmed their positions, while 1 fully exited VTRS. The total reported sell value was $98.93 M.

Yes, 1 managers opened new positions in VTRS, and 5 increased their existing holdings. The total reported buy value was $68.26 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
5.13% Reduce -3.8% 75,232,254 $1.19 B Q2 2026
2.86% Add 8.7% 9,877,409 $156.85 M Q2 2026
0.03% Reduce -26.0% 4,694,966 $74.56 M Q2 2026
0.16% Reduce -2.8% 4,374,683 $69.47 M Q2 2026
1.13% Add 52.6% 2,773,470 $44.04 M Q2 2026
0.11% Add 134.0% 1,698,341 $26.97 M Q2 2026
0.30% Add 11.3% 1,425,546 $23.14 M Q2 2026
0.34% New Buy 1,430,654 $22.72 M Q2 2026
2.75% Add 0.2% 733,164 $11.64 M Q2 2026
0.01% Reduce -68.3% 563,129 $8.94 M Q2 2026
0.03% Reduce -4.5% 177,000 $2.81 M Q2 2026
0.25% Reduce -1.0% 57,696 $916,212 Q2 2026
0.00% Reduce -49.6% 21,119 $335,370 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form